Greenamyre TJ - Search Results

1

Phospholipase iPLA₂β averts ferroptosis by eliminating a redox lipid death signal.

Sun WY, Tyurin VA, Mikulska-Ruminska K, Shrivastava IH, Anthonymuthu TS, Zhai YJ, Pan MH, Gong HB, Lu DH, Sun J, Duan WJ, Korolev S, Abramov AY, Angelova PR, Miller I, Beharier O, Mao GW, Dar HH, Kapralov AA, Amoscato AA, Hastings TG, Greenamyre TJ, Chu CT, Sadovsky Y, Bahar I, Bayır H, Tyurina YY, He RR, Kagan VE. Sun WY, et al. Among authors: greenamyre tj. Nat Chem Biol. 2021 Apr;17(4):465-476. doi: 10.1038/s41589-020-00734-x. Epub 2021 Feb 4. Nat Chem Biol. 2021. PMID: 33542532 Free PMC article.

2

Measurement of LRRK2 Kinase Activity by Proximity Ligation Assay.

Keeney MT, Hoffman EK, Greenamyre TJ, Di Maio R. Keeney MT, et al. Among authors: greenamyre tj. Bio Protoc. 2021 Sep 5;11(17):e4140. doi: 10.21769/BioProtoc.4140. eCollection 2021 Sep 5. Bio Protoc. 2021. PMID: 34604446 Free PMC article.

3

Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial.

McGarry A, McDermott MP, Kieburtz K, Fung WLA, McCusker E, Peng J, de Blieck EA, Cudkowicz M; Huntington Study Group 2CARE Investigators and Coordinators. McGarry A, et al. Neurology. 2019 Apr 2;92(14):e1643-e1651. doi: 10.1212/WNL.0000000000007244. Epub 2019 Mar 8. Neurology. 2019. PMID: 30850442 Free PMC article.

4

Motor, cognitive, and functional declines contribute to a single progressive factor in early HD.

Schobel SA, Palermo G, Auinger P, Long JD, Ma S, Khwaja OS, Trundell D, Cudkowicz M, Hersch S, Sampaio C, Dorsey ER, Leavitt BR, Kieburtz KD, Sevigny JJ, Langbehn DR, Tabrizi SJ; TRACK-HD, COHORT, CARE-HD, and 2CARE Huntington Study Group Investigators. Schobel SA, et al. Neurology. 2017 Dec 12;89(24):2495-2502. doi: 10.1212/WNL.0000000000004743. Epub 2017 Nov 15. Neurology. 2017. PMID: 29142089 Free PMC article.

5

Natural history of Huntington disease.

Dorsey ER, Beck CA, Darwin K, Nichols P, Brocht AF, Biglan KM, Shoulson I; Huntington Study Group COHORT Investigators. Dorsey ER, et al. JAMA Neurol. 2013 Dec;70(12):1520-30. doi: 10.1001/jamaneurol.2013.4408. JAMA Neurol. 2013. PMID: 24126537

6

A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease.

HORIZON Investigators of the Huntington Study Group and European Huntington's Disease Network. HORIZON Investigators of the Huntington Study Group and European Huntington's Disease Network. JAMA Neurol. 2013 Jan;70(1):25-33. doi: 10.1001/2013.jamaneurol.382. JAMA Neurol. 2013. PMID: 23108692 Clinical Trial.

7

Characterization of a large group of individuals with huntington disease and their relatives enrolled in the COHORT study.

Huntington Study Group COHORT Investigators; Dorsey E. Huntington Study Group COHORT Investigators, et al. PLoS One. 2012;7(2):e29522. doi: 10.1371/journal.pone.0029522. Epub 2012 Feb 16. PLoS One. 2012. PMID: 22359536 Free PMC article. Clinical Trial.

8

Synthesis and biological evaluation in mice of (2-[11C]methoxy)-6',7'-dihydrorotenol, a second generation rotenoid for marking mitochondrial complex I activity.

Charalambous A, Tluczek L, Frey KA, Higgins DS Jr, Greenamyre TJ, Kilbourn MR. Charalambous A, et al. Among authors: greenamyre tj. Nucl Med Biol. 1995 May;22(4):491-6. doi: 10.1016/0969-8051(94)00129-8. Nucl Med Biol. 1995. PMID: 7550026 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page